Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference
March 02 2021 - 7:00AM
Business Wire
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology),
a biopharmaceutical company committed to advancing new medicines
for patients battling cancer, today announced that the Company will
participate in the virtual H.C. Wainwright Global Life Sciences
Conference. The fireside chat will be made available for on-demand
listening beginning Tuesday, March 9, 2021 at 7:00 a.m. EST.
The webcast of the fireside chat will be available on the
“Media” section of the Company’s website at www.verastem.com under
“Events & Presentations”.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage
biopharmaceutical company committed to the development and
commercialization of new medicines to improve the lives of patients
diagnosed with cancer. Our pipeline is focused on novel small
molecule drugs that inhibit critical signaling pathways in cancer
that promote cancer cell survival and tumor growth, including
RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For
more information, please visit www.verastem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210302005061/en/
Verastem Oncology Contacts: Investors: Ajay Munshi Vice
President, Corporate Development +1 781-469-1579
amunshi@verastem.com Sherri Spear Argot Partners +1 212 600 1902
sherri@argotpartners.com Media: Lisa Buffington Corporate
Communications +1 781-292-4205 lbuffington@verastem.com
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Apr 2023 to Apr 2024